| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 29 | |
| #2 | Canada | 26 | |
| #3 | Mexico | 16 | |
| #4 | Brazil | 14 | |
| #5 | Israel | 13 | |
| #6 | Norway | 13 | |
| #7 | South Africa | 13 | |
| #8 | Australia | 12 | |
| #9 | Poland | 12 | |
| #10 | WIPO (World Intellectual Property Organization) | 12 | |
| #11 | Bulgaria | 11 | |
| #12 | Czechia | 11 | |
| #13 | Slovakia | 11 | |
| #14 | New Zealand | 9 | |
| #15 | Hungary | 8 | |
| #16 | Hong Kong | 5 | |
| #17 | United States | 4 | |
| #18 | Uruguay | 2 | |
| #19 | China | 1 | |
| #20 | Colombia | 1 | |
| #21 | Germany | 1 | |
| #22 | Peru | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Machines | |
| #4 | Biotechnology | |
| #5 | Measurement | |
| #6 | Agriculture | |
| #7 | Foods and drinks |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Heterocyclic compounds | |
| #4 | Acyclic or carbocyclic compounds | |
| #5 | Unspecified technologies | |
| #6 | Peptides | |
| #7 | Analysing materials | |
| #8 | Microorganisms | |
| #9 | Animal care | |
| #10 | Special foods |
| # | Name | Total Patents |
|---|---|---|
| #1 | Mendel Carl M | 83 |
| #2 | Seaton Timothy B | 74 |
| #3 | Weinstein Steve P | 70 |
| #4 | Watts John Paul | 26 |
| #5 | Rafferty Paul | 23 |
| #6 | Arnold Lee D | 21 |
| #7 | Brough Paul Andrew | 18 |
| #8 | Cheetham Sharon Crawford | 18 |
| #9 | Kerrigan Frank | 18 |
| #10 | Heal David John | 17 |
| Publication | Filing date | Title |
|---|---|---|
| BG105996A | Use of n-substituted derivatives of 1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine for the production of a medicine for treating eating disorders | |
| AU5577301A | Human caspase-14 compositions | |
| DE10114762A1 | Treatment of lung diseases, especially adult respiratory distress syndrome, by administration of cysteine protease inhibitor, especially calpain inhibitor | |
| WO0170273A1 | The use of anticoagulant agents in the extracorporeal treatment of blood | |
| CZ20013283A3 | Medicament for treating increase in weight | |
| CA2368416A1 | Treatment of gallstones | |
| CA2366652A1 | Treatment of pulmonary hypertension | |
| WO0054765A1 | Method of treating eating disorders | |
| IL145243D0 | Weight loss after pregnancy | |
| EP1178790A1 | Treatment to lower platelet adhesiveness | |
| CZ20013279A3 | Pharmaceutical composition |